End-of-day quote
Johannesburg S.E.
03:30:00 26/04/2024 am IST
|
5-day change
|
1st Jan Change
|
285.6
ZAR
|
-0.10%
|
|
+0.54%
|
-12.31%
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
50,275
|
57,192
|
74,296
|
72,708
|
66,179
|
67,991
|
-
|
-
|
Enterprise Value (EV)
1 |
47,662
|
55,040
|
72,089
|
70,693
|
63,724
|
65,656
|
65,203
|
64,643
|
P/E ratio
|
29.6
x
|
30.6
x
|
40.7
x
|
28.9
x
|
26.2
x
|
24
x
|
21.5
x
|
19.4
x
|
Yield
|
2.24%
|
1.96%
|
1.62%
|
2.14%
|
2.48%
|
2.68%
|
3%
|
3.35%
|
Capitalization / Revenue
|
1.6
x
|
1.66
x
|
1.99
x
|
1.84
x
|
1.59
x
|
1.5
x
|
1.37
x
|
1.26
x
|
EV / Revenue
|
1.52
x
|
1.6
x
|
1.93
x
|
1.79
x
|
1.53
x
|
1.45
x
|
1.31
x
|
1.2
x
|
EV / EBITDA
|
17.7
x
|
14.1
x
|
17.3
x
|
14.2
x
|
12.4
x
|
11.5
x
|
10.3
x
|
9.27
x
|
EV / FCF
|
-
|
59.4
x
|
44.4
x
|
65.5
x
|
26.8
x
|
20.5
x
|
16.9
x
|
12.6
x
|
FCF Yield
|
-
|
1.68%
|
2.25%
|
1.53%
|
3.73%
|
4.88%
|
5.91%
|
7.94%
|
Price to Book
|
10.2
x
|
11
x
|
15.5
x
|
12.8
x
|
11.1
x
|
10.7
x
|
9.31
x
|
8.18
x
|
Nbr of stocks (in thousands)
|
2,52,640
|
2,48,663
|
2,45,557
|
2,43,970
|
2,41,971
|
2,38,062
|
-
|
-
|
Reference price
2 |
199.0
|
230.0
|
302.6
|
298.0
|
273.5
|
285.6
|
285.6
|
285.6
|
Announcement Date
|
24/10/19
|
22/10/20
|
27/10/21
|
20/10/22
|
26/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
31,352
|
34,364
|
37,339
|
39,587
|
41,622
|
45,393
|
49,597
|
53,983
|
EBITDA
1 |
2,692
|
3,898
|
4,157
|
4,971
|
5,142
|
5,688
|
6,329
|
6,976
|
EBIT
1 |
2,321
|
2,767
|
2,897
|
3,325
|
3,623
|
4,106
|
4,594
|
5,083
|
Operating Margin
|
7.4%
|
8.05%
|
7.76%
|
8.4%
|
8.7%
|
9.05%
|
9.26%
|
9.42%
|
Earnings before Tax (EBT)
1 |
2,364
|
2,584
|
2,642
|
3,639
|
3,471
|
3,951
|
4,381
|
4,853
|
Net income
1 |
1,703
|
1,880
|
1,838
|
2,523
|
2,538
|
2,870
|
3,204
|
3,575
|
Net margin
|
5.43%
|
5.47%
|
4.92%
|
6.37%
|
6.1%
|
6.32%
|
6.46%
|
6.62%
|
EPS
2 |
6.718
|
7.514
|
7.438
|
10.33
|
10.42
|
11.88
|
13.26
|
14.75
|
Free Cash Flow
1 |
-
|
925.9
|
1,622
|
1,079
|
2,380
|
3,204
|
3,856
|
5,135
|
FCF margin
|
-
|
2.69%
|
4.34%
|
2.73%
|
5.72%
|
7.06%
|
7.77%
|
9.51%
|
FCF Conversion (EBITDA)
|
-
|
23.75%
|
39.02%
|
21.71%
|
46.29%
|
56.32%
|
60.93%
|
73.61%
|
FCF Conversion (Net income)
|
-
|
49.25%
|
88.25%
|
42.79%
|
93.79%
|
111.62%
|
120.35%
|
143.62%
|
Dividend per Share
2 |
4.450
|
4.500
|
4.900
|
6.370
|
6.790
|
7.660
|
8.582
|
9.578
|
Announcement Date
|
24/10/19
|
22/10/20
|
27/10/21
|
20/10/22
|
26/10/23
|
-
|
-
|
-
|
Fiscal Period: August |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
---|
Net sales
1 |
16,857
|
17,508
|
18,134
|
19,205
|
-
|
20,030
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
1,206
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
3.380
|
4.134
|
3.589
|
3.849
|
4.928
|
5.399
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/04/20
|
22/10/20
|
23/04/21
|
27/10/21
|
28/04/22
|
20/10/22
|
Fiscal Period: August |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,614
|
2,152
|
2,207
|
2,015
|
2,455
|
2,335
|
2,787
|
3,348
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
926
|
1,622
|
1,079
|
2,380
|
3,204
|
3,856
|
5,135
|
ROE (net income / shareholders' equity)
|
36.5%
|
37.7%
|
38.2%
|
48%
|
43.6%
|
45.7%
|
44.9%
|
44%
|
ROA (Net income/ Total Assets)
|
13.8%
|
12.4%
|
-
|
-
|
13.8%
|
14.5%
|
14.8%
|
15%
|
Assets
1 |
12,322
|
15,172
|
-
|
-
|
18,388
|
19,827
|
21,595
|
23,760
|
Book Value Per Share
2 |
19.50
|
20.90
|
19.60
|
23.40
|
24.70
|
26.80
|
30.70
|
34.90
|
Cash Flow per Share
2 |
7.440
|
6.060
|
9.360
|
7.850
|
13.60
|
15.20
|
17.30
|
19.10
|
Capex
1 |
647
|
591
|
690
|
838
|
930
|
883
|
868
|
858
|
Capex / Sales
|
2.06%
|
1.72%
|
1.85%
|
2.12%
|
2.23%
|
1.95%
|
1.75%
|
1.59%
|
Announcement Date
|
24/10/19
|
22/10/20
|
27/10/21
|
20/10/22
|
26/10/23
|
-
|
-
|
-
|
Last Close Price
285.6
ZAR Average target price
309.9
ZAR Spread / Average Target +8.52% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.31% | 3.61B | | -32.21% | 15.27B | | -31.97% | 10.84B | | -30.42% | 6.06B | | +8.14% | 6.04B | | -11.41% | 5.86B | | -0.88% | 4.71B | | +52.19% | 4.29B | | -14.86% | 3.33B | | -6.93% | 3.01B |
Other Drug Retailers
|